Mechanical thrombectomy with CEREGLIDE 71 Intermediate Catheter: A single-center post-market experience

Objective: To assess the efficacy and safety of the CEREGLIDE 71 Intermediate Catheter in a real-world clinical setting. Methods: This was a retrospective, single-center, post-market observational study. All consecutive patients with acute ischemic stroke (AIS) who underwent mechanical thrombectomy (MT) with CEREGLIDE 71 between October 2024 and September 2025 were included. The primary outcome was the rate of successful recanalization (final modified Thrombolysis in Cerebral Infarction [mTICI] ≥2b). Secondary efficacy outcomes included complete revascularization (final mTICI ≥2c), first-pass mTICI ≥2c, and first-pass mTICI ≥2b. Safety and clinical outcomes included device-related adverse events, such as vessel dissection, perforation, or catheter breakage, and good functional outcome at 90 days (modified Rankin Scale [mRS] score ≤2). The subgroup of patients treated with a direct aspiration first-pass technique (ADAPT) as the first-line approach was also analyzed. Results: A total of 75 patients underwent MT with CEREGLIDE 71 between October 2024 and September 2025. First-line technique was ADAPT in 76% of procedures (57/75) and combined technique in 24% (18/75). Successful revascularization (mTICI ≥2b) was achieved in 88.0% of patients (66/75). Good functional outcome (90-day mRS ≤2) was observed in 57.3% of patients (43/75). No device-related adverse events were recorded. In the ADAPT subgroup, the SNAKE technique allowed the catheter to reach the clot in 93.0% of cases (53/57). Conclusions: CEREGLIDE 71 appeared to be a feasible and effective option for MT in patients with AIS due to large vessel occlusion (LVO), reaching the occlusion site with the SNAKE technique alone in most procedures.

Authors

Institutions

Publication Details

Journal
Journal of Cerebrovascular and Endovascular Neurosurgery
Published
2026-11-18
DOI
https://doi.org/10.7461/jcen.2026.e2026.06.011
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mechanical thrombectomy with CEREGLIDE 71 Intermediate Catheter: A single-center post-market experience

Pietro Trombatore, Gianluca Galvano, Simone Cottonaro, Alfio Cannella et al.
6 links
Journal of Cerebrovascular and Endovascular Neurosurgery
Acute Ischemic Stroke Management
article

Mechanical thrombectomy with CEREGLIDE 71 Intermediate Catheter: A single-center post-market experience

Pietro Trombatore, Gianluca Galvano, Simone Cottonaro, Alfio Cannella, Antonio Ragusa, Clara Di Lorenzo
article en

Abstract

Objective: To assess the efficacy and safety of the CEREGLIDE 71 Intermediate Catheter in a real-world clinical setting. Methods: This was a retrospective, single-center, post-market observational study. All consecutive patients with acute ischemic stroke (AIS) who underwent mechanical thrombectomy (MT) with CEREGLIDE 71 between October 2024 and September 2025 were included. The primary outcome was the rate of successful recanalization (final modified Thrombolysis in Cerebral Infarction [mTICI] ≥2b). Secondary efficacy outcomes included complete revascularization (final mTICI ≥2c), first-pass mTICI ≥2c, and first-pass mTICI ≥2b. Safety and clinical outcomes included device-related adverse events, such as vessel dissection, perforation, or catheter breakage, and good functional outcome at 90 days (modified Rankin Scale [mRS] score ≤2). The subgroup of patients treated with a direct aspiration first-pass technique (ADAPT) as the first-line approach was also analyzed. Results: A total of 75 patients underwent MT with CEREGLIDE 71 between October 2024 and September 2025. First-line technique was ADAPT in 76% of procedures (57/75) and combined technique in 24% (18/75). Successful revascularization (mTICI ≥2b) was achieved in 88.0% of patients (66/75). Good functional outcome (90-day mRS ≤2) was observed in 57.3% of patients (43/75). No device-related adverse events were recorded. In the ADAPT subgroup, the SNAKE technique allowed the catheter to reach the clot in 93.0% of cases (53/57). Conclusions: CEREGLIDE 71 appeared to be a feasible and effective option for MT in patients with AIS due to large vessel occlusion (LVO), reaching the occlusion site with the SNAKE technique alone in most procedures.

Journal of Cerebrovascular and Endovascular Neurosurgery
Ospedale Garibaldi (IT)
Good health and well-being
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon